Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Panayiotidis MI"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 27
Tytuł:
Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells.
Autorzy:
Anestopoulos I; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus.
Paraskevaidis I; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus.
Kyriakou S; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus.
Giova LE; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus.
Trafalis DT; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Botaitis S; Department of Surgery, School of Medicine, University Hospital, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Franco R; School of Veterinary Medicine & Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.; Redox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.
Pappa A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 27; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Histones*/metabolism
Melanoma*
Benzamides*
Biphenyl Compounds*
Morpholines*
Pyridones*
Humans ; Polycomb Repressive Complex 2/genetics ; Lysine/metabolism ; Enhancer of Zeste Homolog 2 Protein/genetics ; Apoptosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
Autorzy:
Figlioli G; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
Billaud A; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Kvist A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, 22185 Lund, Sweden.
Adank MA; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Family Cancer Clinic, 1066 CX Amsterdam, The Netherlands.
Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.
Auvinen P; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Oncology, University of Eastern Finland, 70210 Kuopio, Finland.; Department of Oncology, Cancer Center, Kuopio University Hospital, 70210 Kuopio, Finland.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Bermisheva M; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, 450054 Ufa, Russia.
Bogdanova NV; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Bojesen SE; Copenhagen General Population Study, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.; Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany.
Camp NJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Campbell A; Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh EH4 2XU, UK.; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH16 4UX, UK.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, 36312 Vigo, Spain.
Cessna MH; Intermountain Health, Salt Lake City, UT 84111, USA.
Nbcs Collaborators; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, 0379 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.; Department of Research, Vestre Viken Hospital, 3019 Drammen, Norway.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.; Section for Breast- and Endocrine Surgery, Department of Cancer, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Ullevål, 0450 Oslo, Norway.; Department of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.; Department of Pathology, Akershus University Hospital, 1478 Lørenskog, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Department of Oncology, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Radiumhospitalet, 0379 Oslo, Norway.; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, 0379 Oslo, Norway.; Department of Oncology, Akershus University Hospital, 1478 Lørenskog, Norway.; Oslo Breast Cancer Research Consortium, Oslo University Hospital, 0379 Oslo, Norway.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
Devilee P; Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Dörk T; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Flyger H; Department of Breast Surgery, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
Gago-Dominguez M; Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS) Foundation, IDIS Cancer Genetics and Epidemiology Group, Genomic Medicine Group, Complejo Hospitalario Universitario de Santiago, SERGAS, 15706 Santiago de Compostela, Spain.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON M5G 1X5, Canada.; Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada.
Gómez Garcia EB; Department of Clinical Genetics, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
González-Neira A; Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Medicine, Institute for Clinical Research and Systems Medicine, Health and Medical University, 14467 Potsdam, Germany.
Guénel P; CESP U1018, Inserm 'Exposome, Heredity, Cancer and Health' Team, UVSQ, University Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.
Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Hamann U; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, 69120 Heidelberg, Germany.
Hillemanns P; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tübingen, 72074 Tübingen, Germany.
Howell A; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
kConFab Investigators; Research Department, Peter MacCallum Cancer Center, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3000, Australia.
Jakubowska A; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Khusnutdinova EK; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, 450054 Ufa, Russia.; Department of Genetics and Fundamental Medicine, Ufa University of Science and Technology, 450076 Ufa, Russia.
Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0379 Oslo, Norway.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Loizidou MA; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.
Lubiński J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210 Kuopio, Finland.; Kuopio University Hospital, Biobank of Eastern Finland, 70210 Kuopio, Finland.
Maurer T; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, 711 10 Heraklion, Greece.
Newman WG; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Obi N; University Medical Center Hamburg-Eppendorf, Institute for Medical Biometry and Epidemiology, 20246 Hamburg, Germany.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.
Radice P; Unit of 'Predictive Medicine: Molecular Bases of Genetic Risk', Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy.
Rashid MU; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, 69120 Heidelberg, Germany.; Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore 54000, Pakistan.
Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Ruebner M; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Saloustros E; Department of Oncology, University Hospital of Larissa, 411 10 Larissa, Greece.
Sawyer EJ; King's College London, School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, London SE1 9RT, UK.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC 3000, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.
Tomlinson I; Cancer Research Centre, The University of Edinburgh, Edinburgh EH4 2XU, UK.
Truong T; CESP U1018, Inserm 'Exposome, Heredity, Cancer and Health' Team, UVSQ, University Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.
van Veen EM; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Wendt C; Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, 118 83 Stockholm, Sweden.
Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.; Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, CA 90069, USA.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Evans DG; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Milne RL; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia.
Peterlongo P; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jun 23; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating the Functional Roles of Aldehyde Dehydrogenase 3A1 in Human Corneal Epithelial Cells.
Autorzy:
Voulgaridou GP; Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Theologidis V; Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Venetikidou M; Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Tsochantaridis I; Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Tsolou A; Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Koffa M; Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Ayios Dometios, Nicosia 2371, Cyprus.
Pappa A; Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 19; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Aldehyde Dehydrogenase*/genetics
Aldehyde Dehydrogenase*/metabolism
Hydrogen Peroxide*/pharmacology
Hydrogen Peroxide*/metabolism
Humans ; Cornea/metabolism ; Epithelial Cells/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Observational study of health utilities in adult primary ciliary dyskinesia patients: preliminary data on associations with molecular diagnosis, clinical phenotype and HRQOL measures.
Autorzy:
Kouis P; Respiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.
Kakkoura MG; Respiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK.
Elia SA; Respiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.; Cyprus International Institute for Environmental & Public Health, Cyprus University of Technology, Limassol, Cyprus.
Ioannou P; Pediatric Pulmonology Unit, Hospital 'Archbishop Makarios III', Nicosia, Cyprus.
Anagnostopoulou P; Respiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.; Pediatric Pulmonology Unit, Hospital 'Archbishop Makarios III', Nicosia, Cyprus.
Potamiti L; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Loizidou MA; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Kyriacou K; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Hadjisavvas A; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Yiallouros PK; Respiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.; Pediatric Pulmonology Unit, Hospital 'Archbishop Makarios III', Nicosia, Cyprus.
Pokaż więcej
Źródło:
Multidisciplinary respiratory medicine [Multidiscip Respir Med] 2022 Dec 20; Vol. 17, pp. 881. Date of Electronic Publication: 2022 Dec 20 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer.
Autorzy:
Giatromanolaki A; Department of Pathology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Mitrakas A; Department of Pathology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Anestopoulos I; Department of Pathology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Kontosis A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Koukourakis IM; Department of Radiotherapy/Oncology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Pappa A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Koukourakis MI; Department of Radiotherapy/Oncology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Apr 01; Vol. 14 (7). Date of Electronic Publication: 2022 Apr 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of Bioactive Properties of Lipophilic Fractions of Edible and Non-Edible Parts of Nasturtium officinale (Watercress) in a Model of Human Malignant Melanoma Cells.
Autorzy:
Kyriakou S; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Tragkola V; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Alghol H; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Anestopoulos I; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Amery T; The Watercress Company, Dorchester DT2 8QY, UK.
Stewart K; Watercress Research Limited, Devon TQ12 4AA, UK.
Winyard PG; Watercress Research Limited, Devon TQ12 4AA, UK.
Trafalis DT; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Franco R; Redox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.; Department of Veterinary Medicine & Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.
Pappa A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2022 Jan 25; Vol. 15 (2). Date of Electronic Publication: 2022 Jan 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Aberrant Mitochondrial Dynamics and Exacerbated Response to Neuroinflammation in a Novel Mouse Model of CMT2A.
Autorzy:
Stavropoulos F; Neuroscience Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Sargiannidou I; Neuroscience Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Potamiti L; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Kagiava A; Neuroscience Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Bae JH; Graduate School of International Agricultural Technology and Institute of GreenBio Science and Technology, Seoul National University, Pyeongchang 25354, Korea.
Yeom SC; Graduate School of International Agricultural Technology and Institute of GreenBio Science and Technology, Seoul National University, Pyeongchang 25354, Korea.
Lee JY; ToolGen Inc., Seoul 08501, Korea.
Kleopa KA; Neuroscience Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.; Center for Neuromuscular Disorders and Center for Multiple Sclerosis and Related Disorders, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 26; Vol. 22 (21). Date of Electronic Publication: 2021 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
Charcot-Marie-Tooth Disease/*genetics
Mitochondria/*genetics
Mitochondrial Dynamics/*genetics
Neuroinflammatory Diseases/*genetics
Neuroinflammatory Diseases/*pathology
Animals ; Disease Models, Animal ; Immunity/genetics ; Inflammation/genetics ; Inflammation/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mitochondria/pathology ; Mitochondrial Proteins/genetics
SCR Disease Name:
Charcot-Marie-Tooth disease, Type 2A
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination of a 15-SNP Polygenic Risk Score and Classical Risk Factors for the Prediction of Breast Cancer Risk in Cypriot Women.
Autorzy:
Yiangou K; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Kyriacou K; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Kakouri E; Department of Medical Oncology, Bank of Cyprus Oncology Center, Nicosia 2012, Cyprus.
Marcou Y; Department of Medical Oncology, Bank of Cyprus Oncology Center, Nicosia 2012, Cyprus.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Loizidou MA; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Hadjisavvas A; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Michailidou K; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.; Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Sep 11; Vol. 13 (18). Date of Electronic Publication: 2021 Sep 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Protective role of taurine against oxidative stress (Review).
Autorzy:
Baliou S; National Hellenic Research Foundation, 11635 Athens, Greece.
Adamaki M; National Hellenic Research Foundation, 11635 Athens, Greece.
Ioannou P; Department of Internal Medicine and Infectious Diseases, University Hospital of Heraklion, 71110 Heraklion, Greece.
Pappa A; Department of Molecular Biology and Genetics, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, 2371 Nicosia, Cyprus.
Spandidos DA; Department of Internal Medicine and Infectious Diseases, University Hospital of Heraklion, 71110 Heraklion, Greece.
Christodoulou I; National Hellenic Research Foundation, 11635 Athens, Greece.
Kyriakopoulos AM; Nasco AD Biotechnology Laboratory, 18536 Pireus, Greece.
Zoumpourlis V; National Hellenic Research Foundation, 11635 Athens, Greece.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2021 Aug; Vol. 24 (2). Date of Electronic Publication: 2021 Jun 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antioxidants/*pharmacology
Oxidative Stress/*drug effects
Taurine/*pharmacology
Animals ; Antioxidants/physiology ; Antioxidants/therapeutic use ; Heart Diseases/drug therapy ; Homeostasis/drug effects ; Homeostasis/physiology ; Humans ; Liver Diseases/drug therapy ; Muscular Diseases/drug therapy ; Nervous System Diseases/drug therapy ; Taurine/physiology ; Taurine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular epidemiology of SARS-CoV-2 in Cyprus.
Autorzy:
Richter J; Molecular Virology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Fanis P; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Molecular Genetics, Function & Therapy Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Tryfonos C; Molecular Virology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Koptides D; Molecular Virology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Krashias G; Molecular Virology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Bashiardes S; Molecular Virology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Hadjisavvas A; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cancer Genetics, Therapeutics & Ultrastructural Pathology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Loizidou M; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cancer Genetics, Therapeutics & Ultrastructural Pathology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Oulas A; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Bioinformatics Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Alexandrou D; Medical and Public Health Services, Ministry of Health, Nicosia, Cyprus.
Kalakouta O; Medical and Public Health Services, Ministry of Health, Nicosia, Cyprus.
Panayiotidis MI; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Cancer Genetics, Therapeutics & Ultrastructural Pathology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Spyrou GM; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; Bioinformatics Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Christodoulou C; Molecular Virology Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 21; Vol. 16 (7), pp. e0248792. Date of Electronic Publication: 2021 Jul 21 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19/*epidemiology
SARS-CoV-2/*genetics
Cyprus/epidemiology ; Humans ; Molecular Epidemiology ; Phylogeny ; SARS-CoV-2/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden.
Autorzy:
Sagredou S; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.
Dalezis P; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.
Papadopoulou E; Genekor Medical, Spaton 52, Ave., 15344 Athens, Greece.
Voura M; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Deligiorgi MV; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.
Nikolaou M; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.; 1st Oncology Department, 'Saint Savas' Anticancer-Oncology Hospital, 11522 Athens, Greece.
Panayiotidis MI; Department of Electron Microscopy & Molecular Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, P.O. Box 23462, Nicosia 1683, Cyprus.
Nasioulas G; Genekor Medical, Spaton 52, Ave., 15344 Athens, Greece.
Sarli V; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Trafalis DT; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2021 Jun 15; Vol. 13 (6). Date of Electronic Publication: 2021 Jun 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Toxicity Profiling of Biosurfactants Produced by Novel Marine Bacterial Strains.
Autorzy:
Voulgaridou GP; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Mantso T; Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK.
Anestopoulos I; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Klavaris A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Katzastra C; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Kiousi DE; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Mantela M; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Galanis A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Gardikis K; Research and Development Department, APIVITA SA, Industrial Park Markopoulo Mesogaias, 19003 Athens, Greece.
Banat IM; Pharmaceutical Science Research Group, Biomedical Science Research Institute, Ulster University, Coleraine, Northern Ireland BT52 1SA, UK.
Gutierrez T; Institute of Mechanical, Process & Energy Engineering, School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK.
Sałek K; Institute of Biological Chemistry, Biophysics & Bioengineering, School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK.
Euston S; Institute of Biological Chemistry, Biophysics & Bioengineering, School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK.
Panayiotidis MI; Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK.; The Cyprus Institute of Neurology and Genetics, Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, PO Box 23462, Nicosia 1683, Cyprus.
Pappa A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Feb 27; Vol. 22 (5). Date of Electronic Publication: 2021 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Bacteria/*metabolism
Keratinocytes/*pathology
Neoplasms/*pathology
Surface-Active Agents/*adverse effects
Surface-Active Agents/*isolation & purification
Apoptosis ; Cell Proliferation ; Humans ; Keratinocytes/drug effects ; Neoplasms/chemically induced ; Toxicity Tests ; Tumor Cells, Cultured
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma.
Autorzy:
Mitsiogianni M; Faculty of Health and Life Sciences, Department of Applied Sciences, Group of Translational Biosciences, Northumbria University, Newcastle Upon Tyne, NE1 8ST, UK.
Trafalis DT; Laboratory of Pharmacology, Clinical Pharmacology Unit, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Franco R; Redox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.; School of Veterinary Medicine & Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, 68583, USA.
Zoumpourlis V; Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635, Athens, Greece.
Pappa A; Department of Molecular Biology and Genetics, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Panayiotidis MI; Faculty of Health and Life Sciences, Department of Applied Sciences, Group of Translational Biosciences, Northumbria University, Newcastle Upon Tyne, NE1 8ST, UK. .; Department of Electron Microscopy and Molecular Pathology, The Cyprus Institute of Neurology and Genetics, 2371, Nicosia, Cyprus. .
Pokaż więcej
Źródło:
European journal of nutrition [Eur J Nutr] 2021 Feb; Vol. 60 (1), pp. 147-158. Date of Electronic Publication: 2020 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Histones*/metabolism
Melanoma*/drug therapy
Melanoma*/genetics
Acetylation ; Animals ; Cell Line, Tumor ; Epigenesis, Genetic ; Histone Acetyltransferases/genetics ; Histone Acetyltransferases/metabolism ; Humans ; Isothiocyanates/pharmacology ; Methylation ; Mice ; Sulfoxides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (Review).
Autorzy:
Baliou S; National Hellenic Research Foundation, 11635 Athens, Greece.
Kyriakopoulos AM; Nasco AD Biotechnology Laboratory, 18536 Pireus, Greece.
Goulielmaki M; National Hellenic Research Foundation, 11635 Athens, Greece.
Panayiotidis MI; Department of Electron Microscopy and Molecular Pathology, The Cyprus Institute of Neurology and Genetics, 2371 Nicosia, Cyprus.
Spandidos DA; Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece.
Zoumpourlis V; National Hellenic Research Foundation, 11635 Athens, Greece.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2020 Sep; Vol. 22 (3), pp. 2163-2173. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Membrane Glycoproteins/*metabolism
Membrane Transport Proteins/*metabolism
Taurine/*analogs & derivatives
Animals ; Feces/chemistry ; Homeostasis ; Humans ; Hydrogen-Ion Concentration ; Kidney/chemistry ; Mice ; Taurine/metabolism ; Taurine/urine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
3,6-Disubstituted 1,2,4-Triazolo[3,4- b ]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha.
Autorzy:
Sagredou S; Laboratory of Pharmacology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece.
Dalezis P; Laboratory of Pharmacology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece.
Nikoleousakos N; Laboratory of Pharmacology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece.
Nikolaou M; Laboratory of Pharmacology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece.
Voura M; Department of Chemistry, Aristotle University of Thessaloniki , Thessaloniki, 54124, Greece.
Almpanakis K; Department of Chemistry, Aristotle University of Thessaloniki , Thessaloniki, 54124, Greece.
Panayiotidis MI; Department of Electron Microscopy & Molecular Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; The Cyprus School of Molecular Medicine, Nicosia 1683, Cyprus.
Sarli V; Department of Chemistry, Aristotle University of Thessaloniki , Thessaloniki, 54124, Greece.
Trafalis DT; Laboratory of Pharmacology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece.
Pokaż więcej
Źródło:
OncoTargets and therapy [Onco Targets Ther] 2020 Jul 28; Vol. 13, pp. 7369-7386. Date of Electronic Publication: 2020 Jul 28 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Surface Active Agents and Their Health-Promoting Properties: Molecules of Multifunctional Significance.
Autorzy:
Anestopoulos I; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Kiousi DE; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Klavaris A; Department of Biological Sciences, University of Cyprus, 2109 Nicosia, Cyprus.
Galanis A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Salek K; Institute of Mechanical, Process & Energy Engineering, Heriot Watt University, Edinburgh EH14 4AS, UK.
Euston SR; Institute of Mechanical, Process & Energy Engineering, Heriot Watt University, Edinburgh EH14 4AS, UK.
Pappa A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Panayiotidis MI; Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK.; Department of Electron Microscopy & Molecular Pathology, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, P.O. Box 23462, 1683 Nicosia, Cyprus.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2020 Jul 21; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 21.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Marine-Derived Surface Active Agents: Health-Promoting Properties and Blue Biotechnology-Based Applications.
Autorzy:
Anestopoulos I; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Kiousi DE; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Klavaris A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Maijo M; Division of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Serpico A; Division of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Suarez A; Division of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Sanchez G; Division of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Salek K; Institute of Mechanical, Process & Energy Engineering, Heriot Watt University, Edinburgh EH14 4AS, UK.
Chasapi SA; Department of Pharmacy, University of Patras, 26504 Patra, Greece.
Zompra AA; Department of Pharmacy, University of Patras, 26504 Patra, Greece.
Galanis A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Spyroulias GA; Department of Pharmacy, University of Patras, 26504 Patra, Greece.
Gombau L; Division of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Euston SR; Institute of Mechanical, Process & Energy Engineering, Heriot Watt University, Edinburgh EH14 4AS, UK.
Pappa A; Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Panayiotidis MI; Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK.; Department of Electron Microscopy & Molecular Pathology, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, PO Box 23462, 1683 Nicosia, Cyprus.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2020 Jun 09; Vol. 10 (6). Date of Electronic Publication: 2020 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Biotechnology*
Health*
Surface-Active Agents/*chemistry
Animals ; Humans ; Surface-Active Agents/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma.
Autorzy:
Dalezis P; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Geromichalou E; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Polonifi A; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Sagredou S; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Nikoleousakos N; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Nikolaou M; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Sarli V; Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Panayiotidis MI; Department of Electron Microscopy & Molecular Pathology, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.; The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, 1683 Nicosia, Cyprus.
Trafalis DT; Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 May 16; Vol. 12 (5). Date of Electronic Publication: 2020 May 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 27

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies